BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8826966)

  • 21. Insulin receptor phosphorylation, insulin receptor substrate-1 phosphorylation, and phosphatidylinositol 3-kinase activity are decreased in intact skeletal muscle strips from obese subjects.
    Goodyear LJ; Giorgino F; Sherman LA; Carey J; Smith RJ; Dohm GL
    J Clin Invest; 1995 May; 95(5):2195-204. PubMed ID: 7537758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of insulin-stimulated insulin receptor activation and glucose transport in cultured skeletal muscle cells from obese subjects.
    Pender C; Goldfine ID; Kulp JL; Tanner CJ; Maddux BA; MacDonald KG; Houmard JA; Youngren JF
    Metabolism; 2005 May; 54(5):598-603. PubMed ID: 15877289
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High insulin levels do not influence PC-1 gene expression and protein content in human muscle tissue and hepatoma cells.
    Frittitta L; Sbraccia P; Costanzo BV; Tassi V; D'Adamo M; Spampinato D; Ercolino T; Purrello F; Tamburrano G; Vigneri R; Trischitta V
    Diabetes Metab Res Rev; 2000; 16(1):26-32. PubMed ID: 10707036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of insulin resistance with high fat feeding in rats does not involve either decreased insulin receptor tyrosine kinase activity or membrane glycoprotein PC-1.
    Ozel B; Youngren JF; Kim JK; Goldfine ID; Sung CK; Youn JH
    Biochem Mol Med; 1996 Dec; 59(2):174-81. PubMed ID: 8986641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pretranslational suppression of a glucose transporter protein causes insulin resistance in adipocytes from patients with non-insulin-dependent diabetes mellitus and obesity.
    Garvey WT; Maianu L; Huecksteadt TP; Birnbaum MJ; Molina JM; Ciaraldi TP
    J Clin Invest; 1991 Mar; 87(3):1072-81. PubMed ID: 1999488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of carbohydrate and fat fuels in human skeletal muscle: impact of obesity and NIDDM.
    Mandarino LJ; Consoli A; Jain A; Kelley DE
    Am J Physiol; 1996 Mar; 270(3 Pt 1):E463-70. PubMed ID: 8638694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin action in skeletal muscle from patients with NIDDM.
    Zierath JR; Krook A; Wallberg-Henriksson H
    Mol Cell Biochem; 1998 May; 182(1-2):153-60. PubMed ID: 9609124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A polymorphism (K121Q) of the human glycoprotein PC-1 gene coding region is strongly associated with insulin resistance.
    Pizzuti A; Frittitta L; Argiolas A; Baratta R; Goldfine ID; Bozzali M; Ercolino T; Scarlato G; Iacoviello L; Vigneri R; Tassi V; Trischitta V
    Diabetes; 1999 Sep; 48(9):1881-4. PubMed ID: 10480624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membrane glycoprotein PC-1 and insulin resistance.
    Goldfine ID; Maddux BA; Youngren JF; Frittitta L; Trischitta V; Dohm GL
    Mol Cell Biochem; 1998 May; 182(1-2):177-84. PubMed ID: 9609127
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression of GLUT4 in skeletal muscle from insulin-resistant patients with obesity, IGT, GDM, and NIDDM.
    Garvey WT; Maianu L; Hancock JA; Golichowski AM; Baron A
    Diabetes; 1992 Apr; 41(4):465-75. PubMed ID: 1535055
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucose metabolism in incubated human muscle: effect of obesity and non-insulin-dependent diabetes mellitus.
    Friedman JE; Caro JF; Pories WJ; Azevedo JL; Dohm GL
    Metabolism; 1994 Aug; 43(8):1047-54. PubMed ID: 8052146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of glucose transporter in muscle from insulin-resistant patients.
    Dohm GL; Elton CW; Friedman JE; Pilch PF; Pories WJ; Atkinson SM; Caro JF
    Am J Physiol; 1991 Mar; 260(3 Pt 1):E459-63. PubMed ID: 2003599
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Q121 PC-1 variant and obesity have additive and independent effects in causing insulin resistance.
    Frittitta L; Baratta R; Spampinato D; Di Paola R; Pizzuti A; Vigneri R; Trischitta V
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5888-91. PubMed ID: 11739459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM.
    Pedersen O; Bak JF; Andersen PH; Lund S; Moller DE; Flier JS; Kahn BB
    Diabetes; 1990 Jul; 39(7):865-70. PubMed ID: 2354749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skeletal muscle peroxisome proliferator- activated receptor-gamma expression in obesity and non- insulin-dependent diabetes mellitus.
    Kruszynska YT; Mukherjee R; Jow L; Dana S; Paterniti JR; Olefsky JM
    J Clin Invest; 1998 Feb; 101(3):543-8. PubMed ID: 9449686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overexpression of membrane glycoprotein PC-1 in MDA-MB231 breast cancer cells is associated with inhibition of insulin receptor tyrosine kinase activity.
    Belfiore A; Costantino A; Frasca F; Pandini G; Mineo R; Vigneri P; Maddux B; Goldfine ID; Vigneri R
    Mol Endocrinol; 1996 Nov; 10(11):1318-26. PubMed ID: 8923458
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of obesity on insulin action in NIDDM.
    Campbell PJ; Carlson MG
    Diabetes; 1993 Mar; 42(3):405-10. PubMed ID: 8432411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exercise training increases glycogen synthase activity and GLUT4 expression but not insulin signaling in overweight nondiabetic and type 2 diabetic subjects.
    Christ-Roberts CY; Pratipanawatr T; Pratipanawatr W; Berria R; Belfort R; Kashyap S; Mandarino LJ
    Metabolism; 2004 Sep; 53(9):1233-42. PubMed ID: 15334390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracellular glucose and fat metabolism in identical twins discordant for non-insulin-dependent diabetes mellitus (NIDDM): acquired versus genetic metabolic defects?
    Vaag A; Alford F; Beck-Nielsen H
    Diabet Med; 1996 Sep; 13(9):806-15. PubMed ID: 8891456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.